Abstract
hypertension. It originated in the sixties and remains influential within the field of hypertension 27 research. However, the concept of one central long-term feedback loop, through which arterial 28 pressure is maintained by its influence on renal function, has been questioned. Furthermore, some 29 concepts in the paradigm are undermined by experimental observations. For example, volume 30 retention and increased cardiac output induced by high salt intake do not necessarily lead to 31 increased arterial pressure. Indeed, in multiple models of salt-sensitive hypertension the major 32 abnormality appears to be failure of the vasodilator response to increased cardiac output, seen in 33 salt-resistant animals, rather than an increase in cardiac output itself. There is also evidence that 
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The process begins with 'normal science', where we work within an existing paradigm that defines 52 our scientific approach. But normal science generates anomalies that can only be resolved through a 53 'revolution' which generates a new paradigm to replace the old one. Kuhn defined an anomaly as a 54 "violation of the paradigm-induced expectations that govern normal science" (70). Kuhn's 55 definition of a paradigm included anything "sufficiently unprecedented to attract an enduring group 56 of adherents away from competing modes of scientific activity" and "sufficiently open-ended to 57 leave all sorts of problems for the redefined group of practitioners to resolve" (70). Arthur Guyton 58 and Thomas Coleman's theory of the role of the kidney in long-term control of arterial pressure and 59 the pathogenesis of hypertension fits nicely with this definition. 60 Nevertheless, advancement in science is characterized by the replacement of established 61 paradigms with new ones. This is why paradigms are so useful; they allow us to advance our 62 theoretical understanding of, in our case, human biology and medicine, by making it 'less wrong '. 63 In this article, we examine the anomalies that could be considered to challenge the 'Guytonian 64 paradigm' of the role of the kidney in long-term control of blood pressure. Our intention is not to 65 propose a new paradigm, but to consider where we are in the 'Kuhn cycle' that drives paradigm 66 change (70). We particularly highlight the evidence that, except in experimental models associated 67 with extreme volume retention, both renal excretory dysfunction and dysfunction of the systemic 68 vasculature are associated with the development of hypertension. 69 There is a long history of criticisms of the Guytonian paradigm, dating back to the time soon 70 after the first publications of Guyton, Coleman and colleagues' on the subject (36). Moreover, some 71 of these authors have even suggested what might be called alternative paradigms (20, 65, 71, 89) . In 72 this respect, it could be argued that we have little new to offer. But rather than advocate for or 73 against the Guytonian paradigm, we aim to identify the central questions that should be addressed to 74 advance the field.
The Guytonian paradigm 76 Arthur Guyton described with passion the moment of epiphany, in which he and Thomas 77 Coleman arrived at the interdependent conclusions that define what we will refer to herein as the 78 Guytonian paradigm: (i) that hypertension can only develop if the relationship between arterial 79 pressure and sodium and water excretion is shifted to a higher level of arterial pressure and (ii) that 80 the renal body-fluid mechanism has infinite gain to control arterial pressure (46) . The concept has 81 endured for more than 5 decades, perhaps in part because it shares many of the characteristics of a 82 good theory outlined by Kuhn (69) . That is, the Guytonian paradigm is (i) accurate in the sense that 83 its consequences are largely in agreement with the results of existing experiments. It has been 84 bolstered by the results of computational modelling, which have allowed the predictions of the 85 paradigm to be compared quantitatively with experimental observations. Generally, the more 86 reliably a particular model is able to simulate experimental observations made under disparate 87 conditions, the greater confidence we can have in the theoretical basis of the model. However, 88 concordance between simulated data and the results of real experiments does not necessarily qualify 89 all elements of the model as different models may provide similar results. Models are wonderful 90 workshops of hypotheses, but not necessarily sponsors of reality. The Guytonian paradigm is also 91 (ii) internally consistent and was different from then current concepts, so novel. The great 92 breakaways were the crucial involvement of the kidney in long-term blood pressure control. This of comprehensive modelling of these and associated relationships. It also (iii) has a broad scope, 97 offering a coherent framework for understanding of both physiological control of arterial pressure 98 and the development of hypertension, (iv) is relatively simple, in that its centerpiece comprises only 99 two concepts (above) (45-47) although they imply several operational features based on modelling 100 alone, and (v) has been fruitful in the sense that is has driven multiple lines of research over decades. It is disappointing; however, that the mechanisms of pressure natriuresis remain unclear 102 despite the explosive increase in insight into cellular and molecular biology (30), and that progress 103 with regard to understanding the mechanisms of essential hypertension has been limited.
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The consequence of the paradigm is that sodium excretion is a monotonous function of 105 arterial pressure. Therefore, the long-term set point of arterial pressure must be at the point of 106 intersection of the pressure natriuresis curve and the daily intake of salt and water (23, 47) . That is, 107 arterial pressure varies around an average level that allows maintenance of homeostasis of 108 extracellular fluid volume (Fig. 1 ). There are several important criticisms of the paradigm set out in Thirdly, in most of the experimental studies in which this relationship was derived in intact 123 animals, its slope did not differ measurably from infinity (22), or was even negative (92), 124 compatible with the notion that arterial blood pressure is not sensitive to salt intake. It could be 125 argued that the absence of a finite slope of the pressure-natriuresis relationship under steady-state 126 conditions is the consequence of a long-term regulatory mechanism operating with infinite gain. by the kidney exposed to a lower arterial pressure decreased, but sodium excretion from the kidney 267 exposed to the slightly elevated systemic arterial pressure increased (Fig. 4) . Surprisingly, they surprisingly, neither protocol seems to have been subjected to computer simulations. Yet regardless 284 of their apparent inconsistencies, the findings of these two studies do allow us to conclude that 285 chronic changes in arterial pressure, that are sufficient to alter the activity of the renin-angiotensin 286 system, will reset the relationship between arterial pressure and renal excretory function. However, 287 there is no support for the idea that direct effects of altered renal perfusion pressure on the kidney 288 can reset this relationship. in SS rats exposed to a high salt diet. However, when body weight was not servo-controlled, SS and 326 SR rats had similarly increased blood volume, but MAP increased only in SS rats. In a separate 327 protocol, in which CO was measured by thermodilution, increased dietary salt intake was found to 328 increase CO in both SS and SR rats. Importantly, hypertension only developed in SS rats, because 329 of failure of a compensatory reduction in TPR (Fig. 5) . Thus, while volume retention was a 330 necessary pre-requisite for hypertension in the SS rat, salt-loaded by either intravenous infusion or 331 dietary intake, it appears not to be the critical mediator. Rather, the critical deficit may lie in failure 332 of counter-regulatory mechanisms that control vascular tone. This concept has recently been dubbed the 'vasodysfunction theory' by Kurz and colleagues (71). It has also been central to arguments for 334 a pivotal role of the central nervous system in the development of hypertension (89).
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The findings of Greene and colleagues (44) are consistent with those of Ganguli and 336 colleagues in SS and SR rats, studied under anesthesia three days after commencing a high or low 337 sodium diet (40). That is, CO apparently increased in response to increased salt intake in both SS 338 and SR rats, but TPR fell only in SR rats. Simchon and colleagues described changes in arterial 339 pressure, CO and renal blood flow (RBF) during development and maintenance of hypertension in 340 SS rats on 8% NaCl (102). They found that the increase in MAP after 4 weeks was mediated by 341 increased CO, but at 46 weeks CO was sub-normal and TPR was elevated. They were unable to 342 detect a significant increase in CO in SR rats, although it certainly tended to be increased at the 4 343 week time-point. Importantly, in these three sets of experiments (40, 44, 102) , volume expansion 344 and increased CO was apparently a requirement for development of hypertension in the SS rat. occurs when salt intake is chronically increased (71).
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The considerations described above do not necessarily require us to reject Guyton and 379 Coleman's view of the pathogenesis of hypertension, but they certainly do require it to be deployed 380 with some subtlety, a point emphasized by Guyton and his colleagues (45). We accept the concept 381 that hypertension can occur either in the absence or presence of volume expansion. But the critical 382 subtlety, as we see it, is that we must also accept that a combination of altered renal excretory 
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In conclusion, as pointed out by Guyton and his colleagues (45), the notion that essential 391 hypertension develops initially from salt and water retention, and that increased CO is transformed 392 to increased TPR (Fig. 2) 400 This issue has been reviewed in detail previously (10, 12, 25, 59, 100), so it will only be 401 discussed briefly. There is now strong evidence that the major driver of day-to-day changes in 402 sodium excretion, in response to day-to-day changes in sodium intake, is the renin-angiotensin-403 aldosterone system, at least in animals and humans in which this system is intact. That is, acute and 404 chronic changes in salt and water intake, either orally or via intravenous infusion, are usually 405 accompanied by changes in salt and water excretion that maintain salt and water homeostasis, 406 without appreciable changes in arterial pressure. Indeed, natriuresis has even been observed during 407 acute sodium loading in the face of reduced arterial pressure (1). However, acute and chronic 408 changes in sodium intake are accompanied by marked changes in the activity of the renin-409 angiotensin-aldosterone system, which appears to be the dominant mechanism mediating changes in 410 sodium and water excretion (12). It is also relevant to note that the phenomenon of 'pressure escape' initially described by Reinhardt and colleagues (97) (vide supra), could be abolished by 412 'clamping' the renin-angiotensin-aldosterone system (100) (Fig. 4) . This group also found no 413 significant correlation between spontaneous diurnal variations in arterial blood pressure and the 414 concomitant rates of sodium and volume excretion (100). Thus, it appears that neurohumoral 415 mechanisms can readily over-ride the influence of minor changes in renal perfusion pressure on 416 renal excretory function.
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All of these observations are consistent with the view that the relationship between blood 418 pressure and natriuresis is exquisitely sensitive to neurohumoral status (Fig. 1) . The effects of 419 altered activity of the renin-angiotensin-aldosterone system (or of renal sympathetic nerve activity, 420 atrial natriuretic peptides, or indeed any other regulatory mechanism) may well be considered to be 421 mediated via a shift in the pressure natriuresis relationship. Nevertheless, we also must concede that 422 the major factor that controls short-term changes in salt and water excretion under physiological 423 conditions is neurohumoral status, not renal artery pressure.
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Based on the discussion above, and as suggested previously (12, 100), we can envisage 425 multiple lines of defense against the development of salt-sensitive hypertension (Fig. 6) can lead to loss of the microvasculature (structural rarefaction) (14). 535 Structural rarefaction has been observed in multiple animal models of hypertension, including 536 the spontaneously hypertensive rat (SHR) and reduced renal mass hypertension (42, 52, 78) .
537
Evidence of structural rarefaction has also been obtained in established human hypertension (3), 538 borderline essential hypertension (2), high-output borderline hypertension, and in individuals with a familial predisposition towards hypertension (86). Furthermore, computational models predict that 540 rarefaction could make a significant contribution to the increased vascular resistance in established 541 hypertension (43). There is also evidence that antihypertensive pharmacotherapy can reverse 542 rarefaction (6). But is rarefaction an important factor in the hemodynamic alterations in 
